Drugs / Influenza vaccine GSK1562902A Formulation 2
Influenza vaccine GSK1562902A Formulation 2
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01379937 | Jul 2011 → Aug 2012 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza vaccine GSK1562902A Formulation 2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01379937 ↗ |
| Modality | Vaccine | “AS03B-adjuvanted Influenza A (H5N1) Vaccine” PMID 26551446 ↗ Feb 2016 |
| Route | Intramuscular | “administered intramuscularly in the deltoid region” NCT01379937 ↗ |